Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease

被引:84
作者
Coleman, Nicholas S.
Foley, Stephen
Dunlop, Simon P.
Wheatcroft, Johanna
Blackshaw, Elaine
Perkins, Alan C.
Singh, Gulzar
Marsden, Charles A.
Holmes, Geoffrey K.
Spiller, Robin C. [1 ]
机构
[1] Univ Hosp, Div Gastroenterol, Sch Med & Surg Sci, Nottingham NG7 2UH, England
[2] Univ Nottingham, Dept Med Phys, Nottingham NG7 2RD, England
[3] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England
[4] Derbyshire Royal Infirm, Dept Gastroenterol, Derby DE1 2QY, England
基金
英国惠康基金;
关键词
D O I
10.1016/j.cgh.2006.04.017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Serotonin (5-hydroxytryptamine [5-HT]) is a key modulator of gut function that in excess causes nausea, vomiting, and diarrhea. We recently showed that patients with postinfective irritable bowel syndrome have increased postprandial release of 5-HT associated with low-grade T-cell mediated inflammation. Celiac disease is another common disease in which a T-cell enteropathy is associated with increased mucosal 5-HT levels. Our aim was to determine how this inflammatory lesion influenced 5-HT bioavailability and how changes in 5-HT related to the symptoms of nausea, vomiting, and diarrhea seen in untreated celiac patients. Methods: Fasting plasma and platelet 5-HT and postprandial plasma 5-HT levels were measured after a high-carbohydrate meal in celiac patients (n = 18) and healthy controls (n = 18) using high-pressure liquid chromatography. Dyspepsia was assessed during the postprandial period using a questionnaire. Finally, we compared the histology and mucosal 5-HT levels in duodenal biopsy specimens from celiac patients and controls. Results: Celiac patients had increased 5-HT-containing enterochromaffin cell numbers and significantly higher peak plasma 5-HT levels (P =.0002), postprandial area under the curve (P =.0006), and platelet 5-HT stores (P =.031) than controls. Peak 5-HT levels correlated significantly with postprandial dyspepsia scores (P =.005). Celiac patients had higher duodenal 5-HT levels (P =.007) than controls. Conclusions: Celiac disease is associated with increased mucosal 5-HT content and enhanced 5-HT release from the upper small bowel, which correlates with postprandial dyspepsia. Serotonin excess may mediate dyspeptic symptoms in untreated celiac disease.
引用
收藏
页码:874 / 881
页数:8
相关论文
共 42 条
[1]   Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study [J].
Bearcroft, CP ;
Perrett, D ;
Farthing, MJG .
GUT, 1998, 42 (01) :42-46
[2]  
Benini L, 2001, SCAND J GASTROENTERO, V36, P1044, DOI 10.1080/003655201750422639
[3]   DECREASED DUODENAL MONOAMINE OXIDASE ACTIVITY IN COELIAC DISEASE [J].
CHALLACOMBE, DN ;
SANDLER, M ;
SOUTHGATE, J .
ARCHIVES OF DISEASE IN CHILDHOOD, 1971, 46 (246) :213-+
[4]   INCREASED EXCRETION OF 5-HYDROXYINDOLEACETIC ACID IN URINE OF CHILDREN WITH UNTREATED CELIAC DISEASE [J].
CHALLACOMBE, DN ;
BROWN, GA ;
BLACK, SC ;
STORRIE, MH .
ARCHIVES OF DISEASE IN CHILDHOOD, 1972, 47 (253) :442-+
[5]   INCREASED TISSUE CONCENTRATIONS OF 5-HYDROXYTRYPTAMINE IN DUODENAL MUCOSA OF PATIENTS WITH CELIAC-DISEASE [J].
CHALLACOMBE, DN ;
DAWKINS, PD ;
BAKER, P .
GUT, 1977, 18 (11) :882-886
[6]   Platelet serotonin transporter in coeliac disease [J].
Chiaravalloti, G ;
Marazziti, D ;
Batistini, A ;
Favilli, T ;
Ughi, C ;
Ceccarelli, M ;
Cassano, GB .
ACTA PAEDIATRICA, 1997, 86 (07) :696-699
[7]   Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome [J].
Coates, MD ;
Mahoney, CR ;
Linden, DR ;
Sampson, JE ;
Chen, J ;
Blaszyk, H ;
Crowell, MD ;
Sharkey, KA ;
Gershon, MD ;
Mawe, GM ;
Moses, PL .
GASTROENTEROLOGY, 2004, 126 (07) :1657-1664
[8]  
COLEMAN N, 2002, NEUROASTROENTEROL MO, V14, P603
[9]   Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans [J].
Coleman, NS ;
Marciani, L ;
Blackshaw, E ;
Wright, J ;
Parker, M ;
Yano, T ;
Yamazaki, S ;
Chan, PQ ;
Wilde, K ;
Gowland, PA ;
Perkins, AC ;
Spiller, RC .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (10) :1039-1048
[10]   Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials [J].
Cremonini, F ;
Delgado-Aros, S ;
Camilleri, M .
NEUROGASTROENTEROLOGY AND MOTILITY, 2003, 15 (01) :79-86